The time frame is when Ph1 clinical trial completes and why IMU has mentioned Ph2/Ph3 starting this year so will likely be end of this year, as a supposed shareholder didn't you know this but of course LC is "lying" blah blah blah. BP usually will make their move when they see efficacy which is why they usually occur end of Ph2 clinical trial but we are already seeing efficacy early in Ph1 clinical trial, didn't you know this is how BP operate????
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)